Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000049

President and CEO sold 36,916 shares at an average $20.34 ($750,955)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-06 Sale : show line 1 in the form −29,266 $20.22 $591,759 260,721 D
2025-01-07 Sale : show line 2 in the form −7,650 $20.81 $159,197 253,071 D
Open-market sales · 36,916 sh · avg $20.34 · $750,955
Loading xslF345X05/wk-form4_1736385877.xml…